Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

Li DW, Liu ZQ, Chen W, Yao M, Li GR.

Mol Med Rep. 2014 Jun;9(6):2043-50. doi: 10.3892/mmr.2014.2080. Epub 2014 Mar 28.

PMID:
24681994
[PubMed - in process]
Free PMC Article
2.

Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52.

Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV.

Nat Commun. 2014 Mar 25;5:3496. doi: 10.1038/ncomms4496.

PMID:
24667209
[PubMed - in process]
Free PMC Article
3.

The role of tau in neurodegenerative diseases and its potential as a therapeutic target.

Wolfe MS.

Scientifica (Cairo). 2012;2012:796024. doi: 10.6064/2012/796024. Epub 2012 Dec 19. Review.

PMID:
24278740
[PubMed]
Free PMC Article
4.

Hyperphosphorylation-induced tau oligomers.

Iqbal K, Gong CX, Liu F.

Front Neurol. 2013 Aug 15;4:112. doi: 10.3389/fneur.2013.00112. eCollection 2013.

PMID:
23966973
[PubMed]
Free PMC Article
5.

The importance of tau phosphorylation for neurodegenerative diseases.

Noble W, Hanger DP, Miller CC, Lovestone S.

Front Neurol. 2013 Jul 1;4:83. doi: 10.3389/fneur.2013.00083. eCollection 2013.

PMID:
23847585
[PubMed]
Free PMC Article
6.

Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury.

Wu X, Mao H, Liu J, Xu J, Cao J, Gu X, Cui G.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1282-93. Print 2013.

PMID:
23826409
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Translocation of PKC by yessotoxin in an in vitro model of Alzheimer's disease with improvement of tau and β-amyloid pathology.

Alonso E, Vale C, Vieytes MR, Botana LM.

ACS Chem Neurosci. 2013 Jul 17;4(7):1062-70. doi: 10.1021/cn400018y. Epub 2013 Apr 8.

PMID:
23527608
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.

Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, Zhang M, Yang Y, Cai F, Woodgett J, Song W.

J Clin Invest. 2013 Jan 2;123(1):224-35. doi: 10.1172/JCI64516. Epub 2012 Dec 3.

PMID:
23202730
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Caspase-mediated truncation of tau potentiates aggregation.

Lee S, Shea TB.

Int J Alzheimers Dis. 2012;2012:731063. doi: 10.1155/2012/731063. Epub 2012 Sep 4.

PMID:
22988541
[PubMed]
Free PMC Article
10.

Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease.

Schuh AF, Rieder CM, Rizzi L, Chaves M, Roriz-Cruz M.

ISRN Neurol. 2011;2011:306905. doi: 10.5402/2011/306905. Epub 2011 May 26.

PMID:
22389813
[PubMed]
Free PMC Article
11.

Suppression of autophagy and activation of glycogen synthase kinase 3beta facilitate the aggregate formation of tau.

Kim SI, Lee WK, Kang SS, Lee SY, Jeong MJ, Lee HJ, Kim SS, Johnson GV, Chun W.

Korean J Physiol Pharmacol. 2011 Apr;15(2):107-14. doi: 10.4196/kjpp.2011.15.2.107. Epub 2011 Apr 30.

PMID:
21660151
[PubMed]
Free PMC Article
12.

Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture.

Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W.

Cell Death Dis. 2011 Jun 2;2:e167. doi: 10.1038/cddis.2011.50.

PMID:
21633390
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

GSK-3 in Neurodegenerative Diseases.

Lei P, Ayton S, Bush AI, Adlard PA.

Int J Alzheimers Dis. 2011;2011:189246. doi: 10.4061/2011/189246. Epub 2011 May 4.

PMID:
21629738
[PubMed]
Free PMC Article
14.

Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3.

Mines MA, Beurel E, Jope RS.

Int J Alzheimers Dis. 2011;2011:861072. doi: 10.4061/2011/861072. Epub 2011 May 11.

PMID:
21629713
[PubMed]
Free PMC Article
15.

Amyloid precursor protein processing and Alzheimer's disease.

O'Brien RJ, Wong PC.

Annu Rev Neurosci. 2011;34:185-204. doi: 10.1146/annurev-neuro-061010-113613. Review.

PMID:
21456963
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.

Ferreira A, Bigio EH.

Mol Med. 2011;17(7-8):676-85. doi: 10.2119/molmed.2010.00220. Epub 2011 Mar 21.

PMID:
21442128
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease.

Yu W, Mechawar N, Krantic S, Quirion R.

Am J Pathol. 2010 May;176(5):2209-18. doi: 10.2353/ajpath.2010.090496. Epub 2010 Mar 12.

PMID:
20228227
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Apoptosis and in vitro Alzheimer disease neuronal models.

Calissano P, Matrone C, Amadoro G.

Commun Integr Biol. 2009;2(2):163-9.

PMID:
19513272
[PubMed]
Free PMC Article
19.

Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.

Arnaud LT, Myeku N, Figueiredo-Pereira ME.

J Neurochem. 2009 Jul;110(1):328-42. doi: 10.1111/j.1471-4159.2009.06142.x. Epub 2009 May 3.

PMID:
19457109
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule.

Carrettiero DC, Hernandez I, Neveu P, Papagiannakopoulos T, Kosik KS.

J Neurosci. 2009 Feb 18;29(7):2151-61. doi: 10.1523/JNEUROSCI.4660-08.2009.

PMID:
19228967
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk